Xopenex
Product Images NDC 17478-171

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Xopenex (NDC 17478-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xop06 0006 01

Chemical structure of levalbuterol hydrochloride, the active ingredient in Xopenex, showing the molecular arrangement including hydroxyl groups and the hydrochloride salt.*

FDA Label Image

Xop06 0006 02

A line graph showing mean change in FEV1 (%) over 8 hours for different doses of a product labeled Xopenex by Akorn. The graph compares four groups over time, with percentage change on the Y-axis and time in hours on the X-axis, showing trends in lung function response.*

FDA Label Image

Xop06 0006 03

A line graph showing mean changes in FEV1 (%) over an 8-hour period for five different groups. The x-axis represents time in hours, and the y-axis shows mean change in FEV1 percentage. Five distinct lines represent various dosages or treatment groups, each labeled with specific group identifiers.*

FDA Label Image

Xop06 0006 04

A line graph illustrating mean change in FEV1 (percent) over time (hours) for different doses and types of inhaled substances, including Lev (0.63 and 0.31), Rac (2.5 and 1.25), and Placebo (Pbo). The graph shows variation in effectiveness over a 4-hour period for Xopenex-related active ingredients and placebo.*

FDA Label Image

Xop06 0006 05

A line chart displaying mean change in FEV1 (%) over time (hours) for different dosages of a drug and placebo. The x-axis shows time in hours, and the y-axis shows mean change in FEV1 percentage. Multiple lines represent different dose groups labeled as Lev 0.63, Lev 0.31, Rac 2.5, Rac 1.25, and Pbo (placebo), illustrating the drug's effect compared to placebo over a 4-hour period.*

FDA Label Image

Xop06 0006 06

An instructional diagram showing an Xopenex vial with a shaded area indicating the twist-off tab portion of the vial for proper usage. The diagram labels instructions to twist off the tab at the designated part.*

FDA Label Image

Xop06 0006 07

An instructional illustration showing the top part of a pouch with a 'tear at notch' indicator. An arrow points to a notch on the pouch top where it should be torn open.*

FDA Label Image

Xop06 0006 08

An instructional illustration showing a hand holding a dose of Xopenex medication, with arrows indicating removal or activation of the X-top device. The image is likely instructing how to use or prepare the Xopenex inhalation product.*

FDA Label Image

Xop06 0006 09

An instructional illustration showing a hand inserting a vial into a labeled reservoir. The image demonstrates the correct placement of the vial for use with the device, likely related to Xopenex by Akorn.*

FDA Label Image

Xop06 0006 10

An instructional diagram showing a medication reservoir. Arrows indicate rotating the reservoir to mix or prepare the medication before use.*

FDA Label Image

Xop06 0006 11

An instructional diagram showing parts of a respiratory device labeled with 'Mouthpiece' and 'Reservoir.' The device is depicted in simple contour drawing to clarify its components.*

FDA Label Image

Xop06 0006 12

An instructional illustration showing a face mask and reservoir attached to a nebulizer device. The labels identify the face mask and reservoir components.*

FDA Label Image

Xop06 0006 13

Illustration showing a nebulizer setup with tubing connected to a compressor labeled with a power switch, and a labeled connection point for nebulizer tubing, related to the Xopenex product by Akorn.*

FDA Label Image

Xop06 0006 14

An instructional illustration showing a side view of a person using a mouthpiece attached to a medication inhaler reservoir. The diagram labels the mouthpiece and reservoir to indicate proper inhaler use.*

FDA Label Image

Xop06 0006 15

An instructional diagram showing a face mask connected to a reservoir. The image is a black and white line drawing highlighting the parts labeled 'FACE MASK' and 'RESERVOIR,' typically used to demonstrate a component assembly or usage for respiratory products.*

FDA Label Image

Xop06 0006 16

Label for Xopenex (levalbuterol HCl) Inhalation Solution Concentrate 1.25 mg/0.5 mL by Akorn. The label indicates sterile unit-dose vials, includes storage instructions to protect from light and keep at 20° to 25°C, and highlights "Dilute Before Use" in red. Distributed by Akorn, Inc. and manufactured for Oak Pharmaceuticals, Inc. The label also features barcode and lot/expiration placeholders.*

FDA Label Image

Xop06 0006 17

Packaging label for Xopenex (levalbuterol HCl) Inhalation Solution Concentrate 1.25 mg/0.5 mL by Akorn. The label indicates an inhalation solution concentrate formulated for oral inhalation, presented in 30 sterile unit-dose vials of 0.5 mL each. The concentration and dosage form are clearly stated on a light blue background with red and blue text.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.